Top Story

VIDEO: Pediatric hepatoblastoma ‘tip of the iceberg’ in predicting future disease

October 21, 2019

Atezolizumab-bevacizumab combination extends survival in unresectable HCC

October 21, 2019
The combination of atezolizumab and bevacizumab prolonged survival compared with standard-of-care sorafenib for patients with unresectable hepatocellular carcinoma who…
In the Journals

HCV cure improves survival in post-DAA liver cancer development

October 16, 2019
Patients who developed hepatitis C-related hepatocellular carcinoma after achieving sustained virologic response with interferon-free direct-acting antivirals had a 60%…
Meeting News

NASPGHAN 2019 chronic liver disease symposium provides update for GIs

October 16, 2019
CHICAGO — During this year’s North American Society for Pediatric Gastroenterology, Hepatology & Nutrition annual meeting, Mercedes Martinez, MD, from…
More Headlines »

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Meeting News

Plasma assay of methylated DNA markers detects liver cancer

June 7, 2018
More »